Obesity Management Market Is Expected to Generate Huge Acquisition |Major Vendors - Pfizer Inc., Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., F. Hoffmann-La Roche Ltd Etc.

Market Research Future has recently declared the expansion of a new research study to its thorough collection of research reports “Worldwide Obesity Management Market Research Report 2018”.

Obesity management Market is experiencing moderate growth. Market Research Future (MRFR) has published a research report about the global obesity management market that envisions remarkable increase for this market with 8.4% CAGR (Compound Annual Growth Rate) during the forecast period between 2015 and 2022. In terms of cash, the market is expected to be worth the US $ 6.2 bn.

Obesity management Market - Key Acquisitions

Apollo Endosurgery (USA)

AstraZeneca (UK)

Ethicon, Inc. (USA)

F. Hoffmann-La Roche Ltd (Switzerland)

GlaxoSmithKline PLC (UK)

Herbalife Ltd. (USA)

Merck Sharp & Dohme Corp.,

A subsidiary of Merck & Co., Inc. (USA)

Pfizer Inc. (USA)

GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2690

Obesity Management Market - Growth and Analysis

The key factors driving the market include easily accessible takeaway meals, growing awareness of weight management techniques, growing initiatives by the market players in collaboration, growing initiatives by government to raise awareness about the adverse impact of obesity on health, growth in nuclear families, growing patient population, increasing demand for inexpensive fast food, research and development (R & D) activities, and rising working population.

However, the availability of low-cost alternatives, the high cost of customization, and post-surgical side effects are the major restraining factors affecting the market growth.

Obesity Management Market - Segment

The global obesity management market has been segmented on the basis of lifestyle changes, prescription weight-loss medication, surgery, and lastly region. Based on lifestyle changes, this market has been segmented into dietary changes, exercise, and others.

Prescription weight-loss medication based segmentation segments the market into buproprion & naltrexone (Contrave), lorcaserin (Belviq), orlistat (Xenical), phentermine & topiramate (Qsymia), liraglutide (Saxenda), and others.

On the basis of surgery, the market has been segmented into biliopancreatic diversion with duodenal switch, gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), and others.

Obesity Management Market – Regional Analysis

The regional segmentation of the global obesity management market segments the market into continent-based regional markets namely The Americas (North America & South America), Europe, Asia Pacific, and rest of the world (RoW).

The Americas segment is the biggest regional market although North America alone can be the largest market for Obesity management. Many popular junk food brands whose trademark burgers and pizzas sell like hot cakes are based in this region, with the high purchasing power of people making consume more junk food.

Europe is the second largest regional market for obesity management. Due to the reasons same as the Americas, Western Europe is a bigger market than Eastern Europe. In Western Europe, the biggest markets are France, Germany, Italy, Spain, and the United Kingdom (UK).

The Asia Pacific market is the third largest market. Due to the high population in China and India, junk food brands have a huge market here. So obesity management always has a huge demand in these countries. Other important country-specific markets in the Asia Pacific are Japan and South Korea, followed by the rest of the Asia Pacific region.

BROWSE COMPLETE 75 PAGES PREMIUM RESEARCH REPORT ENABLED WITH RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312

This release was published on openPR.